Skip navigation

Pharma's Market

SPECIAL REPORT


Current DateTime: 07:33:25 27 Nov 2009
LinksList Documentid: 32984624

PHARMA'S MARKET VIDEO

» More

Current DateTime: 07:33:26 27 Nov 2009
LinksList Documentid: 31171988
Expiration DateTime: 11/27/2009 7:36:08 PM

RSS FEED

» Help

Current DateTime: 07:33:27 27 Nov 2009
LinksList Documentid: 31171995
powered by digg
IMS Health Writes A New Script
Published: Thursday, 8 Oct 2009 | 3:19 PM ET
Text Size
By: Mike Huckman
Reporter

With $137 billion worth of brand name drugs going generic over the next several years, the recession and the looming threat of healthcare reform a lot of people have been running scared about what it all means for pharma. So, surprise, surprise! This morning IMS Health, which closely monitors the industry, came out with its annual forecast and it now says the American drug market is going to grow this year instead of shrink. And not at a bad clip either. RX [RX  Loading...      ()   ] also raised its U.S. growth rate for next year. As I write this, all of the big pharma stocks are trading higher.

But shares of McKesson Corporation [MCK  Loading...      ()   ], which have been on an absolute tear over the last several months, are hitting another new intra-day high today. Lazard Capital Markets' analyst Tom Gallucci raised his price target on the drug distribution company's stock by 10 bucks to $68 specifically because of the IMS report. "Stronger overall market growth is positive and offers a more robust macro backdrop for key services companies in the drug channel," Gallucci wrote. He also bumped up his target by $3 on competitor AmerisourceBergen [ABC  Loading...      ()   ].

To be sure, the IMS forecast isn't all rosy. "Market growth is expected to remain at historically low levels....The economic climate will continue to be a dampening influence in most mature markets, particularly in those countries with rising budget deficits and publicly funded healthcare systems," the report says. So, where to look for strong growth? China. IMS predicts, "China's pharmaceutical market is expected to continue to grow at a 20+ percent pace annually, and contribute 21 percent of of overall global growth through 2013." Wow. More than one-fifth of the drug industry's growth over the next several years will come from one ginormous country with a burgeoning middle class that presumably will be buying more pills.

The major pharmaceutical companies these days love to talk about how they're busy increasing their footprint in China. I'd bet each one would tell you they've got the biggest head start or the best master plan to capitalize on that market. Zhu ni hao yun. (Thanks Melissa Lee.)

Questions?  Comments?  and follow me on Twitter at mhuckman

© 2009 CNBC, Inc. All Rights Reserved
Add This share icon
Text Size
  • digg share
ADD COMMENTS
Remaining characters


Current DateTime: 06:14:06 27 Nov 2009
LinksList Documentid: 29778428

Current DateTime: 09:11:31 27 Nov 2009
LinksList Documentid: 29779196

Current DateTime: 10:38:14 27 Nov 2009
LinksList Documentid: 29779199

Current DateTime: 07:56:30 27 Nov 2009
LinksList Documentid: 29779198
  Data is a real-time snapshot  *Data is delayed at least 15 minutes
Global Business and Financial News, Stock Quotes, and Market Data and Analysis

© 2009 CNBC, Inc.  All Rights Reserved.
A Division of NBC Universal
Thomson ReutersThomson Reuters